FA
BMY icon

Fountainhead AM’s Bristol-Myers Squibb BMY Stock Holding History

Fountainhead AM’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66K Sell
46
-150
-77% -$8.61K ﹤0.01% 211
2026
Q1 		$11.9K Buy
196
+55
+39% +$3.21K 0.01% 187
2025
Q4 		$7.61K Sell
141
-14,830
-99% -$713K 0.01% 140
2025
Q3 		$675K Sell
14,971
-807
-5% -$37.7K 0.09% 96
2025
Q2 		$730K Buy
15,778
+161
+1% +$7.9K 0.11% 79
2025
Q1 		$952K Sell
15,617
-743
-5% -$43.3K 0.15% 55
2024
Q4 		$925K Sell
16,360
-365
-2% -$20.4K 0.17% 54
2024
Q3 		$865K Sell
16,725
-301
-2% -$14.1K 0.18% 49
2024
Q2 		$707K Buy
17,026
+228
+1% +$10.2K 0.17% 53
2024
Q1 		$911K Buy
16,798
+1,277
+8% +$65.1K 0.22% 49
2023
Q4 		$796K Buy
15,521
+131
+0.9% +$6.88K 0.22% 50
2023
Q3 		$893K Sell
15,390
-432
-3% -$26.5K 0.31% 35
2023
Q2 		$1.01M Sell
15,822
-674
-4% -$45.2K 0.36% 30
2023
Q1 		$1.14M Buy
16,496
+130
+0.8% +$9.17K 0.45% 27
2022
Q4 		$1.18M Buy
16,366
+113
+0.7% +$8.52K 0.53% 24
2022
Q3 		$1.16M Buy
16,253
+1,256
+8% +$91.1K 0.58% 25
2022
Q2 		$1.16M Buy
14,997
+2,724
+22% +$207K 0.63% 20
2022
Q1 		$896K Sell
12,273
-5,120
-29% -$344K 0.4% 25
2021
Q4 		$1.08M Buy
17,393
+150
+0.9% +$8.8K 0.47% 21
2021
Q3 		$1.02M Sell
17,243
-4,692
-21% -$309K 0.49% 20
2021
Q2 		$1.39M Sell
21,935
-1,183
-5% -$77.1K 0.74% 17
2021
Q1 		$1.46M Buy
23,118
+10,289
+80% +$640K 0.78% 17
2020
Q4 		$796K Buy
+12,829
New +$789K 0.5% 21

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fountainhead AM's BMY Position: Q2 2026 in Review

Fountainhead AM reduced its Bristol-Myers Squibb (BMY) stake by 77% in Q2 2026, selling an estimated $8.61K and leaving 46 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #211.

Fountainhead AM first reported a position in BMY in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.46M in Q1 2021. 2,524 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Fountainhead AM held 46 shares of Bristol-Myers Squibb worth $2.66K as of Q2 2026.
  • Fountainhead AM sold 150 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.61K.
  • Bristol-Myers Squibb made up ﹤0.01% of Fountainhead AM's portfolio in Q2 2026, its #211 holding.
  • Fountainhead AM first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 23 quarters since.
  • Fountainhead AM's Bristol-Myers Squibb position peaked at $1.46M in Q1 2021.
  • 2,524 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Fountainhead AM's 13F filing for Q2 2026, filed 3 Aug 2026.